Adial Pharmaceuticals Company Leadership

Adial Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.7936) % which means that it has lost $0.7936 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5501) %, meaning that it created substantial loss on money invested by shareholders. Adial Pharmaceuticals' management efficiency ratios could be used to measure how well Adial Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -2.47. The value of Return On Capital Employed is expected to slide to -2.46. At this time, Adial Pharmaceuticals' Non Current Assets Total are quite stable compared to the past year. Other Assets is expected to rise to about 422.6 K this year, although the value of Net Tangible Assets will most likely fall to about 2.7 M. Common Stock Shares Outstanding is expected to rise to about 897.8 K this year, although the value of Net Loss is projected to rise to (16.6 M). Almost 94.17 percent of Adial Pharmaceuticals outstanding shares are held by general public with 2.08 (percent) owned by insiders and only 3.75 % by other corporate entities. Some institutional investors establish a significant position in stocks such as Adial Pharmaceuticals in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Adial Pharmaceuticals, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Adial Pharmaceuticals Workforce Comparison

Adial Pharmaceuticals Insider Trading History

Adial Pharmaceuticals Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Adial Pharmaceuticals often depends on how effective the management is. Adial Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Adial management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Adial management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adial Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Adial Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on Adial's balance sheet. Smart investors calculate Adial Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Adial Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.

Understanding that Adial Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Adial Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.